Publicaciones en las que colabora con BÁRBARA DOMÍNGUEZ ASENJO (12)

2023

  1. Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates

    Biomolecules, Vol. 13, Núm. 4

2022

  1. Axenic interspecies and intraclonal hybrid formation in Leishmania: Successful crossings between visceral and cutaneous strains

    PLoS neglected tropical diseases, Vol. 16, Núm. 2, pp. e0010170

2021

  1. Bioluminescent Imaging Identifies Thymus, As Overlooked Colonized Organ, in a Chronic Model of Leishmania donovani Mouse Visceral Leishmaniasis

    ACS Infectious Diseases, Vol. 7, Núm. 4, pp. 871-883

  2. Ex Vivo Phenotypic Screening of Two Small Repurposing Drug Collections Identifies Nifuratel as a Potential New Treatment against Visceral and Cutaneous Leishmaniasis

    ACS Infectious Diseases, Vol. 7, Núm. 8, pp. 2390-2401

  3. Reproduction in trypanosomatids: Past and present

    Biology, Vol. 10, Núm. 6

2020

  1. DNA flowerstructure co-localizes with human pathogens in infected macrophages

    Nucleic acids research, Vol. 48, Núm. 11, pp. 6081-6091

  2. Mannose-decorated dendritic polyglycerol nanocarriers drive antiparasitic drugs to leishmania infantum-infected macrophages

    Pharmaceutics, Vol. 12, Núm. 10, pp. 1-21

2019

  1. Antiparasitic effect of synthetic aromathecins on Leishmania infantum

    BMC Veterinary Research, Vol. 15, Núm. 1

  2. Current and promising novel drug candidates against visceral leishmaniasis

    Pure and Applied Chemistry

  3. Walking a tightrope: drug discovery in visceral leishmaniasis

    Drug Discovery Today, Vol. 24, Núm. 5, pp. 1209-1216

2018

  1. Chapter 17: DNA Topoisomerases as Promising Targets for Leishmania Chemotherapy

    RSC Drug Discovery Series (Royal Society of Chemistry), pp. 348-370

2017

  1. PEGylated Dendritic Polyglycerol Conjugate Delivers Doxorubicin to the Parasitophorous Vacuole in Leishmania infantum Infections

    Macromolecular Bioscience, Vol. 17, Núm. 10